Replimune Group Inc sell BMO Capital Markets
Start price
23.07.25
/
50%
€2.40
Target price
23.07.26
€1.70
Performance (%)
66.67%
Price
16.10.25
€3.96
Summary
This prediction is currently active. The price for Replimune Group Inc has massively increased, which is bad news for the SELL prediction by BMO_Capital_Markets. This prediction currently runs until 23.07.26. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Replimune Group Inc | 3.665% | 3.665% |
| iShares Core DAX® | -2.465% | 2.641% |
| iShares Nasdaq 100 | -2.812% | 3.120% |
| iShares Nikkei 225® | -0.345% | 6.386% |
| iShares S&P 500 | -2.640% | 1.894% |
Comments by BMO_Capital_Markets for this prediction
In the thread Replimune Group Inc diskutieren
Replimune Group, Inc. (NASDAQ: REPL) was downgraded by analysts at BMO Capital Markets from an "outperform" rating to an "underperform" rating. They now have a $2.00 price target on the stock.
Ratings data for REPL provided by MarketBeat
Stopped prediction by BMO_Capital_Markets for Replimune Group Inc
Replimune Group Inc
Start price
Target price
Perf. (%)
€12.90
22.01.25
22.01.25
€25.92
22.01.26
22.01.26
-69.30%
16.10.25
16.10.25
Replimune Group Inc
Start price
Target price
Perf. (%)
€15.40
22.11.24
22.11.24
€17.31
22.11.25
22.11.25
-74.03%
16.10.25
16.10.25